LAKE FOREST, Calif.,
Oct. 31, 2019 /PRNewswire/
-- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading
global provider of innovative medical technologies, is proud to
announce that it has received Health Canada Certification for
multiple new products which will further expand its penetration
into the Canadian market. Included in this certification are
Morpheus8 and AccuTite, two clinically proven technologies which
have dominated the US market as the leading choice of aesthetic
solutions for physicians.
Morpheus8 is a proprietary Subdermal Adipose Remodeling Device
(SARD) which has disrupted the US aesthetics market, and created a
new category exclusive to InMode. The Morpheus8 certification is
the first product in a line of industry leading technologies
designed specifically to morph aging skin and contour the body. The
triple action of fat coagulation, connective tissue contraction and
bulk heating of the skin, molds the skin subdermally, and provides
patients with long lasting results, without surgery and
downtime.
AccuTite is the smallest minimally invasive technology
available, designed specifically to contour small areas with
pinpoint accuracy. Its innovative design delivers precision radio
frequency heating, enabling physicians to provide their patients
with precise treatments that can be done under local anesthesia, in
an office setting, and in less than 20 minutes.
"Expanding our product portfolio with disruptive
technologies is critical for accelerating
the growth of the InMode brand globally.
Canada is a key market for
us, and the introduction of these products are prime examples
of our commitment to deliver innovative
life-changing technologies," said Shakil
Lakhani, President of InMode North America.
Dr. Spero Theodorou, InMode's
Chief Medical Officer commented, "We are pleased to bring Morpheus8
and AccuTite to our Canadian patients. These technologies have
opened new horizons, providing minimally invasive options for
patients who are looking for long lasting results with minimal
downtime, with safety and efficacy in mind."
In conjunction with these two product launches, Health Canada
certification was also obtained for an alternate version of our
existing flagship BodyTite technology which is currently sold in
the Canadian market. BodyTite is designed to deliver
three-dimension skin contraction previously only achieved through
extensive surgical procedures.
For more information about InMode and our wide array of medical
technologies, visit www.inmodemd.com.
About InMode
InMode is a leading global provider
of innovative medical technologies. InMode develops, manufactures,
and markets devices harnessing novel radio frequency ("RF")
technology. InMode strives to enable new emerging surgical
procedures as well as improve existing treatments. InMode has
leveraged its medically-accepted minimally invasive RF technologies
to offer a comprehensive line of products across several categories
for plastic surgery, gynecology, dermatology, otolaryngology, and
ophthalmology. For more information about InMode, please visit
www.inmodemd.com.
Press Contact:
Behrman Communications
Amanda Reinstein
areinstein@behrmanpr.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Tel: 917-607-8654
View original content to download
multimedia:http://www.prnewswire.com/news-releases/inmode-receives-health-canada-certification-for-multiple-new-products-300949111.html
SOURCE InMode